Does ALOGLIPTIN Cause Interstitial lung disease? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Interstitial lung disease have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 2.5% of all adverse event reports for ALOGLIPTIN.
34
Reports of Interstitial lung disease with ALOGLIPTIN
2.5%
of all ALOGLIPTIN reports
4
Deaths
21
Hospitalizations
How Dangerous Is Interstitial lung disease From ALOGLIPTIN?
Of the 34 reports, 4 (11.8%) resulted in death, 21 (61.8%) required hospitalization, and 3 (8.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN Cause?
Pemphigoid (98)
Pancreatitis (66)
Diarrhoea (60)
Nausea (60)
Rash (55)
Hypoglycaemia (46)
Vomiting (44)
Pancreatitis acute (43)
Drug ineffective (42)
Pruritus (42)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ALOGLIPTIN Alternatives Have Lower Interstitial lung disease Risk?
ALOGLIPTIN vs ALOGLIPTIN\METFORMIN
ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN vs ALOSETRON
ALOGLIPTIN vs ALPELISIB
ALOGLIPTIN vs ALPHA.-LIPOIC ACID